761 related articles for article (PubMed ID: 19376587)
1. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
[TBL] [Abstract][Full Text] [Related]
2. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
[TBL] [Abstract][Full Text] [Related]
3. Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
Vajaranant TS; Fishman GA; Szlyk JP; Grant-Jordan P; Lindeman M; Seiple W
Ophthalmology; 2008 Apr; 115(4):723-9. PubMed ID: 18201765
[TBL] [Abstract][Full Text] [Related]
4. Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome.
Poloschek CM; Kloeckener-Gruissem B; Hansen LL; Bach M; Berger W
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4096-104. PubMed ID: 18487380
[TBL] [Abstract][Full Text] [Related]
5. Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation.
Renner AB; Fiebig BS; Cropp E; Weber BH; Kellner U
Arch Ophthalmol; 2009 Jul; 127(7):907-12. PubMed ID: 19597113
[TBL] [Abstract][Full Text] [Related]
6. Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.
Murro V; Mucciolo DP; Passerini I; Palchetti S; Sodi A; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2099-2111. PubMed ID: 28752371
[TBL] [Abstract][Full Text] [Related]
7. Clinical findings in a carrier of a new mutation in the choroideremia gene.
Potter MJ; Wong E; Szabo SM; McTaggart KE
Ophthalmology; 2004 Oct; 111(10):1905-9. PubMed ID: 15465555
[TBL] [Abstract][Full Text] [Related]
8. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration.
Schmitz-Valckenberg S; Bültmann S; Dreyhaupt J; Bindewald A; Holz FG; Rohrschneider K
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4470-6. PubMed ID: 15557456
[TBL] [Abstract][Full Text] [Related]
9. Fundus albipunctatus associated with compound heterozygous mutations in RPE65.
Schatz P; Preising M; Lorenz B; Sander B; Larsen M; Rosenberg T
Ophthalmology; 2011 May; 118(5):888-94. PubMed ID: 21211845
[TBL] [Abstract][Full Text] [Related]
10. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
11. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.
Mura M; Sereda C; Jablonski MM; MacDonald IM; Iannaccone A
Arch Ophthalmol; 2007 Aug; 125(8):1107-13. PubMed ID: 17698759
[TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
13. Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.
Michaelides M; Wilkie SE; Jenkins S; Holder GE; Hunt DM; Moore AT; Webster AR
Ophthalmology; 2005 Aug; 112(8):1442-7. PubMed ID: 15953638
[TBL] [Abstract][Full Text] [Related]
14. Autofluorescence and infrared retinal imaging in patients and obligate carriers with neuronal ceroid lipofuscinosis.
Kelly JP; Weiss AH; Rowell G; Seigel GM
Ophthalmic Genet; 2009 Dec; 30(4):190-8. PubMed ID: 19852577
[TBL] [Abstract][Full Text] [Related]
15. High-resolution images of retinal structure in patients with choroideremia.
Syed R; Sundquist SM; Ratnam K; Zayit-Soudry S; Zhang Y; Crawford JB; MacDonald IM; Godara P; Rha J; Carroll J; Roorda A; Stepien KE; Duncan JL
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):950-61. PubMed ID: 23299470
[TBL] [Abstract][Full Text] [Related]
16. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
[TBL] [Abstract][Full Text] [Related]
17. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction.
Roosing S; van den Born LI; Hoyng CB; Thiadens AA; de Baere E; Collin RW; Koenekoop RK; Leroy BP; van Moll-Ramirez N; Venselaar H; Riemslag FC; Cremers FP; Klaver CC; den Hollander AI
Ophthalmology; 2013 Jun; 120(6):1239-46. PubMed ID: 23499059
[TBL] [Abstract][Full Text] [Related]
18. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U
Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
[TBL] [Abstract][Full Text] [Related]
19. Large gene deletion and changes in corneal endothelial cells in a family with choroideremia.
Lee SY; Yu WK; Lin PK
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1887-93. PubMed ID: 25722215
[TBL] [Abstract][Full Text] [Related]
20. IMPG2-associated retinitis pigmentosa displays relatively early macular involvement.
van Huet RA; Collin RW; Siemiatkowska AM; Klaver CC; Hoyng CB; Simonelli F; Khan MI; Qamar R; Banin E; Cremers FP; Theelen T; den Hollander AI; van den Born LI; Klevering BJ
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3939-53. PubMed ID: 24876279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
